Letko, Brosseau & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.18M | Sell |
38,325
-1,675
| -4% | -$139K | 0.06% | 68 |
|
|
2025
Q1 | $3.24M | Sell |
40,000
-2,950
| -7% | -$239K | 0.07% | 67 |
|
|
2024
Q4 | $3.87M | Sell |
42,950
-5,000
| -10% | -$450K | 0.07% | 70 |
|
|
2024
Q3 | $4.74M | Sell |
47,950
-8,950
| -16% | -$884K | 0.09% | 72 |
|
|
2024
Q2 | $5.28M | Sell |
56,900
-8,900
| -14% | -$825K | 0.1% | 74 |
|
|
2024
Q1 | $6.24M | Hold |
65,800
| – | – | 0.11% | 74 |
|
|
2023
Q4 | $5.88M | Hold |
65,800
| – | – | 0.11% | 72 |
|
|
2023
Q3 | $4.8M | Sell |
65,800
-4,500
| -6% | -$329K | 0.09% | 73 |
|
|
2023
Q2 | $5.85M | Sell |
70,300
-7,200
| -9% | -$599K | 0.11% | 72 |
|
|
2023
Q1 | $5.91M | Sell |
77,500
-500
| -0.6% | -$38.1K | 0.11% | 74 |
|
|
2022
Q4 | $6.47M | Buy |
+78,000
| New | +$6.47M | 0.12% | 79 |
|